HCT Consolidation Improves Survival in Younger MCL Patients

Oncology Peer Review On-The-Go: Minority Treatment Disparities and Clinical Trial Enrollment

Study Provides First Preclinical Evidence of a Bispecific Trifunctional Antibody–Induced Anti-Tumor Vaccination Effect in Neuroblastoma

Oncology Peer Review On-The-Go: Minority Treatment Disparities and Clinical Trial Enrollment

Women's History Month Spotlight: Alison Gulbis, PharmD, BCOP

Stem Cell Transplant Approaches for Patients With Blood Cancers

March 13th 2019

MCL Has More Hospitalization/Infections Regardless of Transplant/Intensity

March 17th 2023

Bortezomib Regimen Yields Notable Efficacy in Waldenström Macroglobulinemia

March 14th 2023

Study Provides First Preclinical Evidence of a Bispecific Trifunctional Antibody–Induced Anti-Tumor Vaccination Effect in Neuroblastoma

Oncology Peer Review On-The-Go: Minority Treatment Disparities and Clinical Trial Enrollment

Women's History Month Spotlight: Alison Gulbis, PharmD, BCOP

Study Provides First Preclinical Evidence of a Bispecific Trifunctional Antibody–Induced Anti-Tumor Vaccination Effect in Neuroblastoma

Stem Cell Transplant Approaches for Patients With Blood Cancers

March 13th 2019

MCL Has More Hospitalization/Infections Regardless of Transplant/Intensity

March 17th 2023

Bortezomib Regimen Yields Notable Efficacy in Waldenström Macroglobulinemia

March 14th 2023

Related Content

Oncology Peer Review On-The-Go: Minority Treatment Disparities and Clinical Trial Enrollment

Recent research found that the disialoganglioside 2–directed bispecific trifunctional antibody has 2 binding sites which allows for a mitigated T-cell anti-tumor response.

Women's History Month Spotlight: Alison Gulbis, PharmD, BCOP

Podcast

The first episode of CancerNetwork's podcast Oncology Peer Review On-The-Go explores disparities in cancer care treatment among minorities and the significance of a representative sample in clinical trials.

Stem Cell Transplant Approaches for Patients With Blood Cancers

Alison Gulbis, PharmD, BCOP, discusses her experience of being a woman in the bone marrow transplant and cellular therapy field.

March 13th 2019

Podcast

Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.

Investigators indicate that although avoiding efficient mantle cell lymphoma treatment due to late effects may seem okay, most long-term health care needs are disease related in patients up to 70 years.

MCL Has More Hospitalization/Infections Regardless of Transplant/Intensity

March 17th 2023

Bortezomib Regimen Yields Notable Efficacy in Waldenström Macroglobulinemia

Investigators indicate that although avoiding efficient mantle cell lymphoma treatment due to late effects may seem okay, most long-term health care needs are disease related in patients up to 70 years.

The addition of bortezomib to dexamethasone plus rituximab and cyclophosphamide appears to improve progression-free survival among those with Waldenström Macroglobulinemia.

March 14th 2023